Was such a pleasure to do a LIVE DEMO of LOWE at the JP Morgan Healthcare conference. As far as I am aware, this was the first time that anyone has done a live software demo in the conference's 42 years. We had the chance to present just a couple of hours before our colleagues at @nvidia take the stage, which I believe is the first time a large technology company will be presenting live in the coveted Monday morning slot. You can feel the shift happening as biopharma increasingly adopts technology tools. And while all of us in TechBio will certainly face obstacles, challenges and failures going forward - that's always part of being in the lead - the future of TechBio just looks more and more inevitable. Check out this video of LOWE to get a tiny peak at what we are doing at @RecursionPharma TODAY, and what we think the entire industry will look like in the coming years... A big shoutout to the team at @RecursionPharma for putting so much work in over the last decade to build what I believe is clearly the leading operating system for drug discovery, and a big thank you to the tireless efforts of the @valence team for bringing LOWE to life to put all that power at all of our fingertips. We can't wait to share more with folks in the coming days. Follow our social to see video of LOWE start a real drug discovery program from scratch, in real time over about ten minutes, interacting with public data, more than 50 PB of Recursion proprietary data, interacting with the outside world by ordering compounds and then interacting with our wetlab by designing and scheduling experiments. We look like what every biopharma company will look like in the future.

Hello #ASHG22! Check out poster PB2257 to learn how we call copy number in the LPA region with #illumina WGS. I’ll be at the poster between 3-4:45 tomorrow

Cardio-CARE had 9,000 #WGS samples, a petabyte's worth of data, to analyze. How did they do it efficiently and accurately? With @illumina #DRAGEN pipelines and #ORA compression of course, reducing analysis to 120 days & data storage by 80%! #genomics... bit.ly/3DrRST3

Checkout PB2257 #ASHG22 by #Illumina's @jon_belyeu, @sedlazeck and Baylor U. They show how to estimate total and allele-specific KIV-2 repeat length, which strongly impacts #CVD risk. A challenging genomic region that provides enormous medical insight, coming to #DRAGEN soon.

Every NovaSeq X comes with #DRAGEN onboard. Powerful compute and analysis to keep pace with this powerhouse sequencer.

Celebrating the launch of NovaSeq 6000Dx with the team! @illumina #IGF2022

"Because of accuracy and speed, we recommend the use of the DRAGEN for secondary analysis of WGS data" - always love it when #DRAGEN is independently tested by customers and it's strengths shine through @illumina #wgs #genomics #accuracy #GATK bit.ly/3SFJsMA

To get a detailed overview of the #SingleCell ATAC-Seq and multiomics workflows, check out the #DRAGEN v4.0 webinar bit.ly/3QC0kmD

Almost half of all the ILMN sequencing runs are performed using DRAGEN as a secondary analysis tool. That is pretty amazing! V4 will make it easier, faster, and more applicable than ever.

Come join us to learn about #DRAGEN v4.0 !

I'm giving a webinar on the latest #DRAGEN release for accurate, comprehensive, and efficient #genomic secondary analysis. Come join us! #Bioinformatics #singlecell #PGx

#DRAGEN is more comprehensive than ever: new single cell ATAC pipeline, PGx, and imputation available with v4.0 out today

#DRAGEN on the cloud enables processing of 100k WGS in 10 days

I'll be at BioIT World next week and would love to connect if you'll also be there!

Very cool new study on detecting repeat expansions with #WGS. ExpansionHunter for accurate detection of repeat expansions is available in #DRAGEN

2021 - Year of the #DRAGEN blog.software.illumina.com/2…

Amazing to see the progress #DRAGEN has made in breaking the #bioinformatics bottleneck. 1 million whole human genomes processed in 2021.

We are preparing to release updated workflows that will mark the official release of version 1.0 of the open-source DRAGEN-GATK. We'll go over the full details of what this release entails in a webinar and Q&A session on Thursday, Dec. 2 from 10AM-11AM EST. See blog for zoom link

DRAGEN v3.9 is here! Scale your secondary analysis on your preferred cloud platform including Microsoft Azure, AWS and ICA. v3.9 enhancements include #RNAVariantCalling and accuracy gains, enabling customers to find answers that matter. #multicloud bit.ly/3CxCwtN